Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Seegene's Seeplex H1N1 test

This article was originally published in The Gray Sheet

Executive Summary

Firm announces availability of its Seeplex FluA ACE Subtyping assay to simultaneously detect H1N1, seasonal human influenza A (H1, H3) and avian influenza A H5 in a single reaction. Most influenza assays test for one viral strain, but these have low accuracy, according to Seegene. Government officials are seeking more sensitive tests as flu season approaches (1"The Gray Sheet" Aug. 24, 2009). Rapid influenza tests already available include Inverness Medical's BinaxNow Influenza A&B, BD's Directigen EZ Flu A+B and Quidel's QuickVue Influenza A+B

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel